医薬品リファレンス
Lonapegsomatropin
Lonapegsomatropin is a medicine in the class endocrine. It is used for growth failure.
- 薬効分類: Endocrine
- 効能・効果: growth failure
最終更新日 出典: US FDA label
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Endocrine
- ATCコード
- H01AC09
- 一般的な剤形
- 注射剤
- 既知の相互作用
- 99 (中等度: 65 · 軽度: 34)
- 商品名
- 2
- 国・市場
- 2
何に使われるか
作用のしくみ
Pegylated human growth hormone (somatropin) that binds the GH receptor on target cells, causing intracellular signalling. It has direct tissue and metabolic effects and indirect effects mediated by IGF-1, and stimulates skeletal growth in pediatric GHD through effects on the epiphyseal growth plates.
成人の通常用量(添付文書の要約)
Adult GHD, age 30 to 60 years with no oral estrogen: start 1.4 mg subcutaneously once weekly; increase monthly based on clinical response and/or IGF-1; maximum 6.3 mg once weekly
妊娠と授乳
- 妊娠
- Unknown No data for lonapegsomatropin in pregnancy; decades of published data for somatropin, its active part, show no drug-related risk of birth defects or miscarriage, and rats showed no harm. Use in pregnancy only if needed.
- 授乳
- Safe No milk data. A large protein expected to pass into milk only slightly; somatropin does not raise normal milk growth hormone levels and has no reported infant effects. LactMed: no special precautions are required.
報告されている副作用
- Viral infection
- Pyrexia
- Cough
- Nausea and vomiting
- Peripheral edema (adults)
禁忌
- Acute critical illness after open heart surgery, abdominal surgery, multiple accidental trauma, or acute respiratory failure
- Hypersensitivity to somatropin or any excipient
- Pediatric patients with closed epiphyses
注意が必要な方
- Severe hypersensitivity including anaphylaxis and angioedema may occur
- Increased risk of neoplasms: monitor for progression or recurrence; second neoplasms in childhood cancer survivors
- Glucose intolerance and diabetes may be unmasked; monitor glucose
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (99)
- Alogliptin + Lonapegsomatropin Moderate
- Alogliptin-metformin + Lonapegsomatropin Moderate
- Alogliptin-pioglitazone + Lonapegsomatropin Moderate
- Bazedoxifene-conjugated estrogens + Lonapegsomatropin Moderate
- Canagliflozin + Lonapegsomatropin Moderate
- Chlorpropamide + Lonapegsomatropin Moderate
- Cyclosporin + Lonapegsomatropin Moderate
- Dapagliflozin + Lonapegsomatropin Moderate
- Dapagliflozin-metformin + Lonapegsomatropin Moderate
- Desogestrel-ethinyl estradiol + Lonapegsomatropin Moderate
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Lonapegsomatropinの完全なモノグラフ(用量、妊娠・授乳、副作用、警告、すべての相互作用)を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Lonapegsomatropin used for?
Lonapegsomatropin is a medicine in the class endocrine. It is used for Growth failure, Growth hormone deficiency.
What side effects have been reported with Lonapegsomatropin?
Viral infection, Pyrexia, Cough, Nausea and vomiting, Peripheral edema (adults).
Can Lonapegsomatropin be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No data for lonapegsomatropin in pregnancy; decades of published data for somatropin, its active part, show no drug-related risk of birth defects or miscarriage, and rats showed no harm. Use in pregnancy only if needed. Breastfeeding: Safe. No milk data. A large protein expected to pass into milk only slightly; somatropin does not raise normal milk growth hormone levels and has no reported infant effects. LactMed: no special precautions are required.
What does Lonapegsomatropin interact with?
MediHelp lists 99 known interactions for Lonapegsomatropin. Moderate: 65 · Minor: 34. The most serious include Alogliptin, Alogliptin-metformin, Alogliptin-pioglitazone.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。